Home/Filings/4/0001399529-21-000133
4//SEC Filing

Paglia Regina M. 4

Accession 0001399529-21-000133

CIK 0001399529other

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 9:32 PM ET

Size

12.1 KB

Accession

0001399529-21-000133

Insider Transaction Report

Form 4
Period: 2021-07-06
Paglia Regina M.
Chief Human Resources Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-07-06+1,7123,431 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-07-061,71211,988 total
    Common Stock (1,712 underlying)
  • Tax Payment

    Common Stock

    2021-07-06$37.05/sh1,404$52,0182,027 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-07-061,4507,250 total
    Common Stock (1,450 underlying)
  • Exercise/Conversion

    Common Stock

    2021-07-06+1,4501,719 total
Footnotes (4)
  • [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
  • [F3]The vesting schedule was amended such that 1,450 RSUs from the second vesting tranche vested on July 6, 2021 with the remainder of the RSUs being subject to the existing vesting terms of the underlying award agreement.
  • [F4]The vesting schedule was amended such that 1,712 RSUs from the first vesting tranche vested on July 6, 2021 with the remainder of the RSUs being subject to the existing vesting terms of the underlying award agreement.

Issuer

Dicerna Pharmaceuticals Inc

CIK 0001399529

Entity typeother

Related Parties

1
  • filerCIK 0001813985

Filing Metadata

Form type
4
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 9:32 PM ET
Size
12.1 KB